North Potomac, MD, United States of America

Ellen Feigal

This inventor holds 2 USPTO granted patents. Top assignees: Genetics Institute, Inc., Other. Active years: 2002-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ellen Feigal. Retrieved from https://idiyas.com/inventor/ellen-feigal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2002-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ellen Feigal

Introduction

Ellen Feigal is a prominent inventor based in N. Potomac, MD (US). She has made significant contributions to the field of medical research, particularly in the treatment of Kaposi's sarcoma. With a total of 2 patents, her work has had a meaningful impact on the medical community.

Latest Patents

Ellen Feigal's latest patents focus on the treatment of Kaposi's sarcoma using IL-12. The methods provided in her patents detail how IL-12 can be utilized to treat Kaposi's sarcoma, especially in cases associated with AIDS. This innovative approach highlights her commitment to advancing medical treatments for serious conditions.

Career Highlights

Throughout her career, Ellen has worked with various organizations, including Genetics Institute, Inc. Her expertise in the field has allowed her to contribute to groundbreaking research and development in cancer treatment.

Collaborations

Ellen has collaborated with notable professionals in her field, including Robert Yarchoan and James M Pluda. These partnerships have further enhanced her research and the effectiveness of her innovations.

Conclusion

Ellen Feigal's contributions to the treatment of Kaposi's sarcoma through her innovative patents demonstrate her dedication to improving medical outcomes. Her work continues to inspire advancements in cancer research and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…